3.52

3.83% -0.14

After Hours: 3.47 -0.05 -1.42%

Sintx Technologies Inc (SINT)

Overview News Price History Financials Discussions Forecast Stock Split

Sintx Technologies Inc stock is traded at $3.52, with a volume of 159.83K. It is down -3.83% in the last 24 hours and down -5.38% over the past month. SINTX Technologies Inc is an advanced ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing primarily on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming an advanced ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have superb bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.

Previous Close:

$3.66

Open:

$3.43

24h Volume:

159.83K

Relative Volume:

0.16

Market Cap:

$4.73M

Revenue:

$1.23M

Net Income/Loss:

$-8.26M

P/E Ratio:

-0.1041

EPS:

-33.8227

Net Cash Flow:

$-14.65M

1W Performance:

+13.55%

1M Performance:

-5.38%

6M Performance:

-35.06%

1Y Performance:

-95.26%

1-Day Range:

$3.36

$3.87

1-Week Range:

$2.83

$4.47

52-Week Range:

$2.01

$105.80

Sintx Technologies Inc Stock (SINT) Company Profile

Name

Sintx Technologies Inc

Sector

Healthcare (1176)

Industry

Medical Devices (148)

Phone

801-839-3516

Address

1885 WEST 2100 STREET, SALT LAKE CITY, UT

Employee

Twitter

@SINTXTech

Next Earnings Date

2024-11-11

Latest SEC Filings

SINT's Discussions on Twitter

Compare SINT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SINT Sintx Technologies Inc	3.52	4.73M	1.23M	-8.26M	-14.65M	-3.8732
ABT Abbott Laboratories	114.23	198.13B	41.22B	5.77B	6.49B	3.29
SYK Stryker Corp	364.60	138.99B	21.97B	3.59B	3.21B	9.33
BSX Boston Scientific Corp	88.95	131.10B	15.91B	1.79B	1.89B	1.21
MDT Medtronic Plc	81.03	103.90B	33.00B	4.29B	5.50B	3.27
EW Edwards Lifesciences Corp	74.81	44.12B	6.60B	4.16B	490.10M	6.93

Sintx Technologies Inc Stock (SINT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-12-19	Initiated	Ascendiant Capital Markets	Buy

Sintx Technologies Inc Stock (SINT) Latest News

Dec 18, 2024

Before You Invest, Make Sure You Check This SINTX Technologies Inc (NASDAQ: SINT) Analysis - Stocks Register

Dec 18, 2024

Dec 17, 2024

SINTX Technologies Secures Patent Allowance for Wide-Ranging Silicon Nitride Biomaterial Applications - GlobeNewswire

Dec 17, 2024

Dec 13, 2024

Sintx Technologies Updates Executive Compensation Agreements - TipRanks

Dec 13, 2024

Nov 29, 2024

Sintx Technologies Appoints CEO Eric Olson to Board - TipRanks

Nov 29, 2024

Nov 26, 2024

SINT (SINTX Technologies) Forward Rate of Return (Yacktman) % : 0.00% (As of Sep. 2024) - GuruFocus.com

Nov 26, 2024

SINT (SINTX Technologies) Capex-to-Operating-Cash-Flow : 0.00 (As of Sep. 2024) - GuruFocus.com

Nov 26, 2024

SINT (SINTX Technologies) 3-Year Revenue Growth Rate : -54.60% (As of Sep. 2024) - GuruFocus.com

Nov 26, 2024

SINT (SINTX Technologies) EPS without NRI : $-164.41 (TTM As of Sep. 2024) - GuruFocus.com

Nov 26, 2024

Stock market news: Alector down -34.47%, SiNtx Technologies -32.97% among the biggest losers during mid day trading - Business Upturn

Nov 26, 2024

SINT (SINTX Technologies) ROE % Adjusted to Book Value : -443.54% (As of Sep. 2024) - GuruFocus.com

Nov 26, 2024

SINT (SINTX Technologies) FCF Margin % : -703.27% (As of Sep. 2024) - GuruFocus.com

Nov 26, 2024

SINT (SINTX Technologies) Momentum Rank : 1 (As of Nov. 26, 2024) - GuruFocus.com

Nov 26, 2024

Nov 25, 2024

SINTX Technologies (LTS:0A8S) Cyclically Adjusted Book per Share : $15,528.10 (As of Sep. 2024) - GuruFocus.com

Nov 25, 2024

SINTX Technologies (LTS:0A8S) Cyclically Adjusted PS Ratio : 0.01 (As of Nov. 25, 2024) - GuruFocus.com

Nov 25, 2024

SINTX Technologies (LTS:0A8S) Cyclically Adjusted Revenue p - GuruFocus.com

Nov 25, 2024

SINTX Technologies (LTS:0A8S) 3-Year Dividend Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com

Nov 25, 2024

SINTX Technologies (LTS:0A8S) 3-Year EBITDA Growth Rate : 64.20% (As of Sep. 2024) - GuruFocus.com

Nov 25, 2024

Nov 24, 2024

SINT (SINTX Technologies) Owner Earnings per Share (TTM) : -13.28 (As of Sep. 2024) - GuruFocus.com

Nov 24, 2024

Nov 23, 2024

SINT (SINTX Technologies) Price-to-Free-Cash-Flow : N/A (As of Nov. 23, 2024) - GuruFocus.com

Nov 23, 2024

Nov 21, 2024

SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment - The Manila Times

Nov 21, 2024

SINTX Technologies and NED Medical Partner to Advance - GlobeNewswire

Nov 21, 2024

SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment - GlobeNewswire Inc.

Nov 21, 2024

Nov 20, 2024

Sintx Technologies (NASDAQ:SINT) vs. LENSAR (NASDAQ:LNSR) Head-To-Head Contrast - Defense World

Nov 20, 2024

Nov 19, 2024

Sintx Technologies (NASDAQ:SINT) Stock Price Up 55.9% – Here’s Why - Defense World

Nov 19, 2024

Sintx Technologies Initiates Stock Repurchase Program - Yahoo Finance

Nov 19, 2024

SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer - GlobeNewswire

Nov 19, 2024

SINTX Technologies Names Wall Street Veteran Gregg Honigblum as Chief Strategy Officer | SINT Stock News - StockTitan

Nov 19, 2024

Sintx Technologies, Inc. Appoints Gregg R. Honigblum as Chief Strategy Officer - Marketscreener.com

Nov 19, 2024

Nov 18, 2024